PFE Dividend Calculator

On December 12, 2025, Pfizer declared its first 2026 dividend at $0.43 a share. That is the same rate it paid all through 2025, so this year is the first in the table without a raise. From 2020 to 2024, the board had added one cent to the quarterly rate each December.

Three 2026 payments have gone ex-dividend so far, for $1.29 per share. On October 6, 2026, Pfizer declared the fourth: $0.43, payable December 7 to holders of record on November 6. Pfizer counts it as its 352nd quarterly dividend in a row.

The yearly payout grew from $1.12 per share in 2015 to $1.72 in 2025. That works out to about 4.4% a year. The size of each raise shrank along the way. Every year from 2016 to 2020 added 8 cents to the yearly total, two cents a quarter.

Since 2021 the step has been one cent a quarter. That made 2021 only 2.6% above 2020, and 2025 only 2.4% above 2024.

Yes, in 2009. When it agreed to buy Wyeth that January, Pfizer halved the quarterly dividend from 32 cents to 16 cents, starting with the second-quarter payment. Its 2009 payout fell to $0.80 a share, from $1.28 in 2008.

It took until 2017 for the quarterly rate to climb back to 32 cents.

No. A Dividend King has raised its payout every year for at least 50 years. Pfizer’s 2009 cut broke any such run, and 2026 brings no raise.

What Pfizer can claim is an unbroken string of payments. The December 2026 dividend will be its 352nd straight quarterly payout.

The payout ratio compares the dividend with earnings per share. In 2025, Pfizer paid $9.8 billion in dividends, or $1.72 a share. Its adjusted earnings were $3.22 a share, so the dividend took about 53% of them.

On reported earnings of $1.36 a share, the dividend was bigger than profit, about 126%. Reported earnings include charges such as asset write-downs that adjusted earnings leave out.

For 2026, Pfizer expects adjusted earnings of $2.80 to $3.00 a share, a range it confirmed on August 4, 2026. At $1.72 a year, that puts the payout ratio at about 57% to 61%. Pfizer says it is committed to keeping the dividend and, over the longer term, growing it.

In 2026 Pfizer went ex-dividend on January 23, May 8 and July 24, and paid on March 6, June 12 and September 1. The ex-date is the same day as the record date. The cash arrives 31 to 42 days later.

Pfizer usually declares its first-quarter dividend in mid-December, and it goes ex-dividend in late January.

As of Oct 13, 2026, PFE yielded about 6.06%: $1.72 a share over the past year, with the stock near $28.38. The $0.43 rate has not moved since early 2025, so for now the yield changes only when the share price does.

Many investors compare Pfizer with Johnson & Johnson (JNJ). On Oct 13, 2026, JNJ yielded about 2.03% against 6.06% for PFE. Pfizer had the higher yield, while JNJ paid more per share: $1.34 a quarter against Pfizer’s $0.43.

The 2026 paths differ too. JNJ raised its quarterly dividend from $1.30 to $1.34, starting with the payment that went ex-dividend in May. Pfizer kept $0.43.

At $0.43 a quarter, 100 PFE shares pay $43 each quarter and $172 a year. Getting $1,000 a month, or $12,000 a year, takes 6,977 shares.

Near $28.38 a share, those 6,977 shares would cost about $198,027. The cash comes four times a year, about $3,000 each time.

As of Oct 13, 2026, PFE yields about 6.06%, having distributed $1.72 per share over the trailing twelve months.

Its most recent payment was $0.43 per share, which went ex-dividend on Jul 24, 2026 and paid on Sep 1, 2026.

PFE has paid a steady $0.43 per share each quarter across the payments shown below.

Pfizer is one of the largest global pharmaceutical companies, with a broad portfolio of vaccines and branded medicines. It pays a quarterly dividend that, after the run-down of pandemic-era revenue, has carried a notably high yield relative to its large-cap peers.

PFE is a high-yield stock from Pfizer that distributes quarterly. Because dividend investing is about both income and the growth of that income, the calculator above lets you model three things independently for PFE: the starting yield, how fast the dividend grows each year, and how fast the share price appreciates. That separation matters most for high-yield versus dividend-growth choices, where a lower starting yield that grows quickly can overtake a higher static yield over time.